Since they targeted the cancer cell rather than immune cells, the mouse colon carcinoma cell line CT26 and human CRC cell line HCT116 confirmed the high expression of CXCR2 in the two cell lines. This evidence concerns the gene CXCR2 and colon carcinoma.